Tradestie Institutional Equity Comparison Engine
OKYO vs ARGX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ARGX Overall Edge
ARGX Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to argenx SE American Depositary Shares (ARGX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ARGX at 27.8x Forward P/E and 31.9% operating margin (+52.1% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ARGX sits in UNCLASSIFIED (33rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ARGX
OKYO N/M vs ARGX 27.8x Fwd P/E
Growth & Margin Winner
ARGX
Op Margin 0.0% vs 31.9% ยท YoY +0.0% vs +52.1%
Momentum & Technical Winner
ARGX
1Y -47.0% vs +1.2% ยท 52W Pos 3% vs 64%
Options & Structure Winner
ARGX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (33rd %ile IV)
OKYO
NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap
$62.7M
1M Return
-27.21%
1Y Return
-47.03%
Forward P/E
N/M
Unified AI Score
42.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 50.0
Mom 45.0
ARGX
NASDAQ
argenx SE American Depositary Shares
Biological Products, (No Diagnostic Substances)
$925.70
-1.73% 1D
Market Cap
$59.3B
1M Return
+5.7%
1Y Return
+1.21%
Forward P/E
27.8x
Unified AI Score
49.6 / 100
HOLD
Tech 38.0
Fund 47.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OKYO -47.03%
ARGX +1.21%
Spread: +48.24 pp (ARGX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OKYO TTM Op. Margin: 0.0%
ARGX TTM Op. Margin: 31.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs ARGX. Trailing 12-month operating profitability (OKYO 0.0% vs ARGX 31.9%) and valuation multiples (OKYO N/M vs ARGX 27.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKYO | ARGX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.7M | $59.3B | Larger Scale | ARGX |
| Trailing P/E Ratio Valuation | N/M | 32.6x | Lower Multiple | ARGX |
| Forward P/E Ratio Valuation | N/M | 27.8x | Lower Multiple | ARGX |
| Revenue Growth (YoY) Growth | +0.0% | +52.1% | Higher Growth | ARGX |
| Operating Margin (TTM) Profitability | 0.0% | 31.9% | Higher Margin | ARGX |
| Net Profit Margin Profitability | 0.0% | 31.7% | Higher Margin | ARGX |
| Return on Equity (ROE) Capital Efficiency | -263.8% | 23.6% | Higher ROE | ARGX |
| 52-Week Range Position Momentum | 3% ($1โ$3) | 64% ($662โ$1,073) | Stronger Trend | ARGX |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 76% Vol | 0.56ฮฒ ยท 31% Vol | Lower Realized Risk | ARGX |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 49.6 / 100 (HOLD) | Higher Composite | ARGX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OKYO vs ARGX Buy Guide
OKYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ARGX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
33rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OKYO nor ARGX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.